Literature DB >> 18403002

Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.

Michael H Baumann1, Robert D Clark, Richard B Rothman.   

Abstract

(+/-)-3,4-Methylenedioxymethamphetamine (MDMA, or Ecstasy) is an illicit drug that evokes transporter-mediated release of monoamines, including serotonin (5-HT) and dopamine (DA). Here we monitored the effects of MDMA on neurochemistry and motor activity in rats, as a means to evaluate relationships between 5-HT, DA, and behavior. Male rats undergoing in vivo microdialysis were housed in chambers equipped with photobeams for measurement of ambulation (i.e., forward locomotion) and stereotypy (i.e., head weaving and forepaw treading). Microdialysis probes were placed into the n. accumbens, striatum or prefrontal cortex in separate groups of rats. Dialysate samples were assayed for 5-HT and DA by microbore HPLC-ECD. Rats received two i.v. injections of MDMA, 1 mg/kg followed by 3 mg/kg 60 min later; neurochemical and locomotor parameters were measured concurrently. MDMA produced dose-related elevations in extracellular 5-HT and DA in all regions, with the magnitude of 5-HT release always exceeding that of DA release. MDMA-induced ambulation was positively correlated with dialysate DA levels in all regions (P<0.05-0.0001) and with dialysate 5-HT in striatum and cortex (P<0.001-0.0001). Stereotypy was strongly correlated with dialysate 5-HT in all areas (P<0.001-0.0001) and with dialysate DA in accumbens and striatum (P<0.001-0.0001). These data support previous work and suggest the complex spectrum of behaviors produced by MDMA involves 5-HT and DA in a region- and modality-specific manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403002      PMCID: PMC2491560          DOI: 10.1016/j.pbb.2008.02.018

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  97 in total

1.  A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.

Authors:  M Shankaran; G A Gudelsky
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

2.  A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

Authors:  L H Gold; C B Hubner; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 3.  Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs.

Authors:  L H Gold; M A Geyer; G F Koob
Journal:  NIDA Res Monogr       Date:  1989

Review 4.  Molecular, pharmacological and functional diversity of 5-HT receptors.

Authors:  Daniel Hoyer; Jason P Hannon; Graeme R Martin
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

5.  Age-related decline in striatal dopamine release and motoric function in brown Norway/Fischer 344 hybrid rats.

Authors:  D M Yurek; S B Hipkens; M A Hebert; D M Gash; G A Gerhardt
Journal:  Brain Res       Date:  1998-04-27       Impact factor: 3.252

6.  The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat.

Authors:  I Creese; S D Iversen
Journal:  Psychopharmacologia       Date:  1974

Review 7.  The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings.

Authors:  N R Swerdlow; F J Vaccarino; M Amalric; G F Koob
Journal:  Pharmacol Biochem Behav       Date:  1986-07       Impact factor: 3.533

Review 8.  Therapeutic and adverse actions of serotonin transporter substrates.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Pharmacol Ther       Date:  2002-07       Impact factor: 12.310

9.  Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats.

Authors:  M H Baumann; M A Ayestas; R B Rothman
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

10.  Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA.

Authors:  Marcy J Bubar; Kami M Pack; Paul S Frankel; Kathryn A Cunningham
Journal:  Psychopharmacology (Berl)       Date:  2004-04-03       Impact factor: 4.530

View more
  52 in total

1.  Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.

Authors:  Pai-Kai Huang; Shawn M Aarde; Deepshikha Angrish; Karen L Houseknecht; Tobin J Dickerson; Michael A Taffe
Journal:  Drug Alcohol Depend       Date:  2012-06-03       Impact factor: 4.492

2.  Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine.

Authors:  J Elliott Robinson; Abigail E Agoglia; Eric W Fish; Michael C Krouse; C J Malanga
Journal:  Behav Brain Res       Date:  2012-06-21       Impact factor: 3.332

3.  Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat.

Authors:  Michael H Baumann; Zakia Williams; Dorota Zolkowska; Richard B Rothman
Journal:  Drug Alcohol Depend       Date:  2010-11-10       Impact factor: 4.492

4.  Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.

Authors:  Ratchanee Rodsiri; Clare Spicer; A Richard Green; Charles A Marsden; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2010-07-20       Impact factor: 4.530

5.  Intravenous self-administration of entactogen-class stimulants in male rats.

Authors:  Sophia A Vandewater; Kevin M Creehan; Michael A Taffe
Journal:  Neuropharmacology       Date:  2015-08-21       Impact factor: 5.250

6.  Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.

Authors:  Charles W Schindler; Eric B Thorndike; Steven R Goldberg; Kurt R Lehner; Nicholas V Cozzi; Simon D Brandt; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2015-08-29       Impact factor: 4.530

7.  Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters.

Authors:  Richard B Rothman; John S Partilla; Michael H Baumann; Catrissa Lightfoot-Siordia; Bruce E Blough
Journal:  J Pharmacol Exp Ther       Date:  2012-01-23       Impact factor: 4.030

8.  Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.

Authors:  Charles W Schindler; Eric B Thorndike; Bruce E Blough; Srihari R Tella; Steven R Goldberg; Michael H Baumann
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

9.  Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Curr Top Behav Neurosci       Date:  2017

10.  Sex differences in abuse-related neurochemical and behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.

Authors:  M F Lazenka; J A Suyama; C T Bauer; M L Banks; S S Negus
Journal:  Pharmacol Biochem Behav       Date:  2016-08-24       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.